[
  {
    "ts": null,
    "headline": "This Iconic Chain Store Is Closing Down. Which Retailer Could File for Bankruptcy Next?",
    "summary": "Drugstore Rite Aid has filed for Chapter 11 again, and this time it’s selling off all its assets to the competition. But retail conditions remain challenging for all. Rite Aid might not be the only big chain store going out of business in 2025.",
    "url": "https://finnhub.io/api/news?id=4d4e6577fa28c86ee7f2c1396ff1c7427fed5f618b6b22480ff28d80b8cd65e8",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1756233012,
      "headline": "This Iconic Chain Store Is Closing Down. Which Retailer Could File for Bankruptcy Next?",
      "id": 136536739,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CVS",
      "source": "Yahoo",
      "summary": "Drugstore Rite Aid has filed for Chapter 11 again, and this time it’s selling off all its assets to the competition. But retail conditions remain challenging for all. Rite Aid might not be the only big chain store going out of business in 2025.",
      "url": "https://finnhub.io/api/news?id=4d4e6577fa28c86ee7f2c1396ff1c7427fed5f618b6b22480ff28d80b8cd65e8"
    }
  },
  {
    "ts": null,
    "headline": "GILD Wins Approval for Twice-Yearly HIV Prevention Shot in the EU",
    "summary": "Gilead secures EU approval for twice-yearly HIV prevention shot Yeytuo, backed by strong trial data and expanded market protection.",
    "url": "https://finnhub.io/api/news?id=75d9b24c0cd17c7275aa5e8b9b7aa3be07b187254ade510a67a413895da9bcca",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1756215600,
      "headline": "GILD Wins Approval for Twice-Yearly HIV Prevention Shot in the EU",
      "id": 136526772,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CVS",
      "source": "Yahoo",
      "summary": "Gilead secures EU approval for twice-yearly HIV prevention shot Yeytuo, backed by strong trial data and expanded market protection.",
      "url": "https://finnhub.io/api/news?id=75d9b24c0cd17c7275aa5e8b9b7aa3be07b187254ade510a67a413895da9bcca"
    }
  },
  {
    "ts": null,
    "headline": "CVS Health Services' Q2 AOI Falls Despite Sales Gain: More Risk Ahead?",
    "summary": "CVS Health's Q2 Health Services revenues climb 10%. Yet, AOI slips as cost pressures and Oak Street's rising MBR ail.",
    "url": "https://finnhub.io/api/news?id=ccb13cb9668f9e698d7895881ea3b90519948fac4d6f4bccf64852a3a0315460",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1756211400,
      "headline": "CVS Health Services' Q2 AOI Falls Despite Sales Gain: More Risk Ahead?",
      "id": 136525671,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CVS",
      "source": "Yahoo",
      "summary": "CVS Health's Q2 Health Services revenues climb 10%. Yet, AOI slips as cost pressures and Oak Street's rising MBR ail.",
      "url": "https://finnhub.io/api/news?id=ccb13cb9668f9e698d7895881ea3b90519948fac4d6f4bccf64852a3a0315460"
    }
  }
]